LAVA Therapeutics
LVTX
LVTX
18 hedge funds and large institutions have $35.2M invested in LAVA Therapeutics in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
18
Holders Change
-2
Holders Change %
-10%
% of All Funds
0.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
3
Reduced
5
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
Millennium Management
New York
|
+$481K |
2 |
Geode Capital Management
Boston,
Massachusetts
|
+$4.48K |
3 |
Axa
Paris,
France
|
+$9 |
Top Sellers
1 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$758K |
2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$117K |
3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$9.56K |
4 |
Morgan Stanley
New York
|
-$6.54K |
5 |
UBS Group
Zurich,
Switzerland
|
-$2.13K |